BetaHCF Case Studies Library is in beta. We're still adding campaigns and fixing things.
HCF Case Studies Library

← All campaigns · Open in the library

▶Videoyoutube.com

Remove the Risk

“Remove the Risk”

FDA education campaign launched 25 April 2019, timed to DEA's National Prescription Drug Take Back Day, urging households to remove unused prescription opioids from the home and dispose of them, preferably through take-back programs.

Years
2019–now
Country
United States
Budget
USD 1,614,050 FDA order 'Education and outreach initiative - opioids medications', Jul 2017-Feb 2021, to IQ Solutions (USAspending)
Topic
Opioids
Asks people to
Start
Strategy
Simple instruction
Channel
PrintRadioSocial (organic)Social (paid)TV
Audience
Adults
Women aged 35-64, described by FDA as household 'gatekeepers' for medicines; English and Spanish toolkit for providers and organizations.

Evidence

NoneUnknown

No outcome evaluation of the campaign found. Related trial evidence: a 2025 meta-analysis of randomized trials found disposal kits, education plus disposal kits (RR 2.00, 95% CI 1.03-3.87) and education with text reminders increased disposal versus routine practice (Ma 2025). A cluster RCT after pediatric orthopaedic surgery found neither preoperative education nor added disposal bins improved disposal (Wahhab 2024).

Sponsor (who paid)

Credits (who made it)

Executions (individual ads)

Related campaigns

Sources

  1. FDA launches campaign to encourage safe removal of unused opioid pain medication from homes (OH&S) news · 2019
  2. FDA campaign encourages public to safely dispose of opioids (AHA News) news · 2019
  3. Remove the Risk campaign material (FDA) sponsor
  4. Ma et al. Effectiveness of interventions designed to increase safe medicine disposal: a systematic review and meta-analysis of randomised trials. Syst Rev 2025 reference · 2025 · DOI 10.1186/s13643-025-02820-4 · PMID 40450368
  5. Wahhab et al. Information and Access for Safe Narcotic Disposal: A Cluster-Randomized Trial Among Pediatric Orthopaedic Surgical Patients in Los Angeles County. J Am Acad Orthop Surg 2024 reference · 2024 · DOI 10.5435/JAAOS-D-24-00276 · PMID 40249599
  6. Safe Opioid Disposal - Remove the Risk Outreach Toolkit (FDA) sponsor

Research notes

Campaign page: fda.gov/removetherisk. The Maryland 'Stop Overdose' site re-uses the materials. Evidence on disposal suggests pairing messages with a disposal kit or take-back access matters more than awareness alone. Checked 2026-10-22: the toolkit page (fda.gov/removetherisk redirects to it) is still live with six video PSAs, four radio PSAs, print PSAs, posters, social graphics and English/Spanish downloads; no 2021+ refresh or new wave was found, and no agency is credited anywhere found. FDA has no consumer education campaign of its own for over-the-counter naloxone (approved 2023) that could be found; federal OTC naloxone awareness ran through ONDCP and the Ad Council (ad-council-naloxone-awareness) and manufacturers (emergent-narcan-ready-to-rescue). Credits checked 2026-10-22 against fetched pages: IQ Solutions case page ('IQ Solutions partnered with FDA to research, develop, launch, and promote Remove the Risk'; reports about 1.8 billion impressions and USD 36 million in ad value, self-reported). Matching contract: HHSF223201710217G (https://www.usaspending.gov/award/CONT_AWD_HHSF223201710217G_7524_GS00F083CA_4732). Possible vendor for PSA distribution: MediaForce LLC, 'Dissemination of FDA education and outreach campaign public service advertisements', 2019-2022, USD 1.60M (contract 75F40119F80440); the record does not name the campaign. Reuse terms checked 2026-10-23 by an AI research pass for #47; not yet reviewed by a person.

Record cases/fda-remove-the-risk.json, updated 2026-10-23· Link to this campaign